CCL21/6Ckine Antibody [Janelia Fluor® 646]
Novus Biologicals, part of Bio-Techne | Catalog # AF366J

Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
Immunocytochemistry, Neutralization, Western Blot
Label
Janelia Fluor 646
Antibody Source
Polyclonal Goat IgG
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
E. coli-derived recombinant human CCL21/6Ckine
Ser24-Pro134
Accession # Q6ICR7
Ser24-Pro134
Accession # Q6ICR7
Specificity
Detects human CCL21/6Ckine in direct ELISAs and Western blots.
Clonality
Polyclonal
Host
Goat
Isotype
IgG
Applications for CCL21/6Ckine Antibody [Janelia Fluor® 646]
Application
Recommended Usage
Immunocytochemistry
Optimal dilutions of this antibody should be experimentally determined.
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Neutralization
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Antigen Affinity-purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: CCL21/6Ckine
Alternate Names
6Ckine, exodus-2, SCYA21, SLC, TCA-4
Gene Symbol
CCL21
Additional CCL21/6Ckine Products
Product Documents for CCL21/6Ckine Antibody [Janelia Fluor® 646]
Product Specific Notices for CCL21/6Ckine Antibody [Janelia Fluor® 646]
Sold under license from the Howard Hughes Medical Institute, Janelia Research Campus.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...